Advil is a brand name for the nonsteroidal anti-inflammatory drug (NSAID) ibuprofen. The global ibuprofen market is expected to grow significantly in the coming years. According to a report by Global Market Insights, the global ibuprofen market is expected to reach $7.5 billion by 2027, with a compound annual growth rate (CAGR) of 3.5% from 2021 to 2027 [2]. Another report by Research Dive estimates that the global ibuprofen market will grow at a CAGR of 2.5% from 2021 to 2028 [3].

While there is no specific data available on Advil's market share growth, we can infer from the growth of the ibuprofen market that Advil's market share is likely to increase. Advil has been a popular brand of ibuprofen for decades, and its popularity is likely to continue as the demand for ibuprofen grows. Additionally, Advil has a strong brand reputation and has been successful in marketing campaigns.

However, it is worth noting that the ibuprofen market is highly competitive, with several other brands and generic versions of ibuprofen available. Advil faces competition from other popular brands such as Motrin and Nurofen, as well as generic versions of ibuprofen. Despite this competition, Advil has maintained a strong market position and is likely to continue to do so in the future.

In conclusion, while there is no specific data available on Advil's market share growth, the growth of the ibuprofen market suggests that Advil's market share is likely to increase. Advil has a strong brand reputation and faces competition from other brands and generic versions of ibuprofen, but is likely to maintain a strong market position.

Sources:
[2] https://www.globenewswire.com/news-release/2022/01/26/2373168/0/en/Ibuprofen-Market-and-Ibuprofen-API-Market-2022-Extensive-Research-By-Latest-Industry-Innovations-Size-Share-Recent-Developments-Market-Position-Growth-Drivers-Business-Opportunity-.html
[3] https://www.drugpatentwatch.com/p/tradename/ADVIL
[4] https://money.yahoo.com/global-ibuprofen-market-2022-growing-145900562.html